Lennon David James 4
4 · Aadi Bioscience, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Lennon David James
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-01+16,250→ 39,119 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−16,250→ 48,750 total→ Common Stock (16,250 underlying) - Sale
Common Stock
2025-03-03$2.35/sh−5,690$13,372→ 33,429 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
- [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.